EP
ANRO icon

Eversept Partners’s Alto Neuroscience ANRO Stock Holding History

Eversept Partners’s Portfolio ANRO Stock Details ANRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.81M Buy
+125,168
New +$2.32M 0.15% 80

Other funds holding ANRO

AWG
Alpha Wave Global New York $791M AUM 113.77% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
SSC
Spruce Street Capital New York $416M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Eversept Partners's ANRO Position: Q1 2026 in Review

Eversept Partners opened a new position in Alto Neuroscience (ANRO) in Q1 2026: 125,168 shares worth $2.81M. The stake represents 0.15% of the portfolio and ranks #80 among its holdings.

110 funds tracked by Wall St. Rank hold ANRO as of Q1 2026.

  • Eversept Partners held 125,168 shares of Alto Neuroscience worth $2.81M as of Q1 2026.
  • Alto Neuroscience was a new Eversept Partners position in Q1 2026.
  • Alto Neuroscience made up 0.15% of Eversept Partners's portfolio in Q1 2026, its #80 holding.
  • 110 funds tracked by Wall St. Rank held Alto Neuroscience as of Q1 2026.

Based on Eversept Partners's 13F filing for Q1 2026, filed 15 May 2026.